Compound Detail
CHEMBL174984
TRETOQUINOL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL174984 |
| Name | TRETOQUINOL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | RGVPOXRFEPSFGH-AWEZNQCLSA-N |
11
Targets
27
Activities
3
Assay Types
0
PK Parameters
20
Publications
12
Known Names
1
Indications
Molecular Properties
345.4
MW (Da)
2.55
ALogP
6
HBA
3
HBD
80.2
PSA (Ų)
0.72
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Lung Diseases, Obstructive
ATC Classification
R03AC09
tretoquinol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03CC09
tretoquinol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
Ki 12 meas. best 7.36
IC50 9 meas. best 8.21
EC50 6 meas. best 8.77
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-3 adrenergic receptor CHEMBL246 | EC50 | 8.77 | 8.77 | 1.7 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 8.46 | 8.46 | 3.5 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 8.21 | 8.21 | 6.1 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 8.21 | 8.21 | 6.1 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | EC50 | 7.85 | 7.85 | 14.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL5414 | EC50 | 7.58 | 7.58 | 26.3 | 1 |
| Adrenergic receptor beta CHEMBL2094118 | EC50 | 7.51 | 7.51 | 31.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 7.36 | 7.36 | 43.6 | 2 |
| Beta-2 adrenergic receptor CHEMBL5414 | Ki | 7.31 | 7.31 | 49.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL5471 | Ki | 7.06 | 7.06 | 87.1 | 1 |
| Adrenergic receptor beta CHEMBL2095166 | Ki | 7.0 | 7.0 | 100.0 | 1 |
| Thromboxane A2 receptor CHEMBL2069 | Ki | 6.79 | 6.775 | 162.2 | 2 |
| Beta-1 adrenergic receptor CHEMBL5471 | EC50 | 6.76 | 6.76 | 173.8 | 1 |
| Thromboxane A2 receptor CHEMBL2069 | IC50 | 6.55 | 6.45 | 281.8 | 2 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 6.49 | 6.49 | 323.6 | 2 |
| Homo sapiens CHEMBL372 | IC50 | 5.94 | 5.076 | 1148.2 | 5 |
| Beta-3 adrenergic receptor CHEMBL246 | Ki | 5.43 | 5.43 | 3715.3 | 1 |
| Dopamine receptor CHEMBL2093868 | Ki | 5.3 | 5.3 | 5000.0 | 1 |
| Adrenergic receptor alpha CHEMBL2094111 | Ki | 5.0 | 5.0 | 10000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31479 | 10.1021/jm00209a019 | Adrenergic receptor beta | 6 |
| 31479 | 10.1021/jm00209a019 | Unchecked | 4 |
| 1346651 | 10.1021/jm00081a007 | Beta-2 adrenergic receptor | 4 |
| 1346651 | 10.1021/jm00081a007 | Beta-1 adrenergic receptor | 4 |
| 9016331 | 10.1021/jm950896w | Beta-2 adrenergic receptor | 3 |
| 10377236 | 10.1021/jm990012z | Beta-3 adrenergic receptor | 3 |
| 10377236 | 10.1021/jm990012z | Beta-2 adrenergic receptor | 3 |
| 10377236 | 10.1021/jm990012z | Beta-1 adrenergic receptor | 3 |
| 11055339 | 10.1016/s0960-894x(00)00459-5 | Beta-2 adrenergic receptor | 3 |
| 11055339 | 10.1016/s0960-894x(00)00459-5 | Beta-1 adrenergic receptor | 3 |
| 2878080 | 10.1021/jm00161a039 | No relevant target | 3 |
| 2869145 | 10.1021/jm00152a003 | Homo sapiens | 3 |
| 9016331 | 10.1021/jm950896w | Beta-1 adrenergic receptor | 3 |
| 9016331 | 10.1021/jm950896w | Homo sapiens | 3 |
| 950642 | 10.1021/jm00228a005 | Unchecked | 3 |
| 6120236 | 10.1021/jm00140a011 | Beta-2 adrenergic receptor | 2 |
| 8809159 | 10.1021/jm960208o | Thromboxane A2 receptor | 2 |
| 11055339 | 10.1016/s0960-894x(00)00459-5 | Beta-3 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 10691685 | 10.1021/jm990463j | Beta-2 adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine